Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Bender JeremyDirector
|
GrantDeferred Restricted Stock Units · Derivative | 117,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-082838 · ownership.xml · derivative · entry 2 Bender Jeremy · CIK 0001863107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,533 Underlying: American Depository Shares · 117,533 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Bender JeremyDirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082838 · ownership.xml · derivative · entry 1 Bender Jeremy · CIK 0001863107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 16:30 UTC |
Ekblom AndersDirector
|
GrantDeferred Restricted Stock Units · Derivative | 133,560 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-082820 · ownership.xml · derivative · entry 2 Ekblom Anders · CIK 0002005817 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,560 Underlying: American Depository Shares · 133,560 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 16:30 UTC |
Ekblom AndersDirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082820 · ownership.xml · derivative · entry 1 Ekblom Anders · CIK 0002005817 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 16:30 UTC |
Shames DanielDirector
|
GrantDeferred Restricted Stock Units · Derivative | 96,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-082826 · ownership.xml · derivative · entry 2 Shames Daniel · CIK 0002005702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,163 Underlying: American Depository Shares · 96,163 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 16:30 UTC |
Shames DanielDirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082826 · ownership.xml · derivative · entry 1 Shames Daniel · CIK 0002005702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082818 · ownership.xml · derivative · entry 1 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
WYZGA MICHAEL SDirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082815 · ownership.xml · derivative · entry 1 WYZGA MICHAEL S · CIK 0001201256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Yoskowitz Marc JDirector
|
GrantDeferred Restricted Stock Units · Derivative | 96,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-082830 · ownership.xml · derivative · entry 2 Yoskowitz Marc J · CIK 0001617306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,163 Underlying: American Depository Shares · 96,163 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Yoskowitz Marc JDirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082830 · ownership.xml · derivative · entry 1 Yoskowitz Marc J · CIK 0001617306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Jenkins AnnalisaDirector
|
GrantDeferred Restricted Stock Units · Derivative | 106,848 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-082835 · ownership.xml · derivative · entry 2 Jenkins Annalisa · CIK 0001639481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,848 Underlying: American Depository Shares · 106,848 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Jenkins AnnalisaDirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082835 · ownership.xml · derivative · entry 1 Jenkins Annalisa · CIK 0001639481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Jacquet PierreDirector
|
GrantDeferred Restricted Stock Units · Derivative | 106,848 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-082831 · ownership.xml · derivative · entry 2 Jacquet Pierre · CIK 0001783451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,848 Underlying: American Depository Shares · 106,848 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:30 UTC |
Jacquet PierreDirector
|
GrantShare Options (Right to buy) · Derivative | 66,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001193125-26-082831 · ownership.xml · derivative · entry 1 Jacquet Pierre · CIK 0001783451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 Underlying: American Depositary Shares · 66,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Fox Christine AnnChief Financial Officer
|
GrantShare Options (Right to buy) · Derivative | 280,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033749 · ownership.xml · derivative · entry 3 Fox Christine Ann · CIK 0002005755 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,000 Underlying: American Depository Shares · 280,000 shares Expires 2036-02-01 F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Fox Christine AnnChief Financial Officer
|
GrantShare Options (Right to buy) · Derivative | 105,250 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001193125-26-033749 · ownership.xml · derivative · entry 2 Fox Christine Ann · CIK 0002005755 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,250 Underlying: American Depository Shares · 105,250 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Fox Christine AnnChief Financial Officer
|
GrantShare Options (Right to buy) · Derivative | 315,750 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033749 · ownership.xml · derivative · entry 1 Fox Christine Ann · CIK 0002005755 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,750 Underlying: American Depositary Shares · 315,750 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Hughes-Wilson AlexandraSee Remarks
|
GrantShare Options (Right to buy) · Derivative | 195,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033753 · ownership.xml · derivative · entry 3 Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,000 Underlying: American Depository Shares · 195,000 shares Expires 2036-02-01 F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Hughes-Wilson AlexandraSee Remarks
|
GrantShare Options (Right to buy) · Derivative | 61,250 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001193125-26-033753 · ownership.xml · derivative · entry 2 Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,250 Underlying: American Depository Shares · 61,250 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Hughes-Wilson AlexandraSee Remarks
|
GrantShare Options (Right to buy) · Derivative | 183,750 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033753 · ownership.xml · derivative · entry 1 Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,750 Underlying: American Depositary Shares · 183,750 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Sermon CharlesGeneral Counsel
|
GrantShare Options (Right to buy) · Derivative | 295,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033752 · ownership.xml · derivative · entry 3 Sermon Charles · CIK 0001687318 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,000 Underlying: American Depository Shares · 295,000 shares Expires 2036-02-01 F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Sermon CharlesGeneral Counsel
|
GrantShare Options (Right to buy) · Derivative | 105,250 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001193125-26-033752 · ownership.xml · derivative · entry 2 Sermon Charles · CIK 0001687318 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,250 Underlying: American Depository Shares · 105,250 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Sermon CharlesGeneral Counsel
|
GrantShare Options (Right to buy) · Derivative | 315,750 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033752 · ownership.xml · derivative · entry 1 Sermon Charles · CIK 0001687318 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,750 Underlying: American Depositary Shares · 315,750 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 21:30 UTC |
Scots-Knight DeniseDirector · Chief Executive Officer
|
GrantShare Options (Right to buy) · Derivative | 480,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033751 · ownership.xml · derivative · entry 3 Scots-Knight Denise · CIK 0001297000 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,000 Underlying: American Depository Shares · 480,000 shares Expires 2036-02-01 F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 21:30 UTC |
Scots-Knight DeniseDirector · Chief Executive Officer
|
GrantShare Options (Right to buy) · Derivative | 345,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001193125-26-033751 · ownership.xml · derivative · entry 2 Scots-Knight Denise · CIK 0001297000 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,000 Underlying: American Depository Shares · 345,000 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 21:30 UTC |
Scots-Knight DeniseDirector · Chief Executive Officer
|
GrantShare Options (Right to buy) · Derivative | 1,035,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033751 · ownership.xml · derivative · entry 1 Scots-Knight Denise · CIK 0001297000 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,035,000 Underlying: American Depositary Shares · 1,035,000 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Lewicki John A.Chief Scientific Officer
|
GrantShare Options (Right to buy) · Derivative | 145,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033754 · ownership.xml · derivative · entry 3 Lewicki John A. · CIK 0001553352 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,000 Underlying: American Depository Shares · 145,000 shares Expires 2036-02-01 F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Lewicki John A.Chief Scientific Officer
|
GrantShare Options (Right to buy) · Derivative | 46,637 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001193125-26-033754 · ownership.xml · derivative · entry 2 Lewicki John A. · CIK 0001553352 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,637 Underlying: American Depository Shares · 46,637 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 01, 2026 Filed Feb 2, 2026 16:30 UTC |
Lewicki John A.Chief Scientific Officer
|
GrantShare Options (Right to buy) · Derivative | 139,913 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001193125-26-033754 · ownership.xml · derivative · entry 1 Lewicki John A. · CIK 0001553352 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,913 Underlying: American Depositary Shares · 139,913 shares Expires 2036-02-01 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Bender JeremyDirector
|
GrantDeferred Restricted Stock Units · Derivative | 16,768 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015433 · ownership.xml · derivative · entry 2 Bender Jeremy · CIK 0001863107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,768 Underlying: American Depository Shares · 16,768 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Bender JeremyDirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015433 · ownership.xml · derivative · entry 1 Bender Jeremy · CIK 0001863107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 16:30 UTC |
Ekblom AndersDirector
|
GrantDeferred Restricted Stock Units · Derivative | 19,054 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015419 · ownership.xml · derivative · entry 2 Ekblom Anders · CIK 0002005817 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 Underlying: American Depository Shares · 19,054 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 16:30 UTC |
Ekblom AndersDirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015419 · ownership.xml · derivative · entry 1 Ekblom Anders · CIK 0002005817 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 16:30 UTC |
Shames DanielDirector
|
GrantDeferred Restricted Stock Units · Derivative | 13,719 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015428 · ownership.xml · derivative · entry 2 Shames Daniel · CIK 0002005702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,719 Underlying: American Depository Shares · 13,719 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 16:30 UTC |
Shames DanielDirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015428 · ownership.xml · derivative · entry 1 Shames Daniel · CIK 0002005702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015423 · ownership.xml · derivative · entry 1 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
WYZGA MICHAEL SDirector
|
GrantDeferred Restricted Stock Units · Derivative | 30,487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015418 · ownership.xml · derivative · entry 2 WYZGA MICHAEL S · CIK 0001201256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,487 Underlying: American Depository Shares · 30,487 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
WYZGA MICHAEL SDirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015418 · ownership.xml · derivative · entry 1 WYZGA MICHAEL S · CIK 0001201256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Yoskowitz Marc JDirector
|
GrantDeferred Restricted Stock Units · Derivative | 13,719 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015426 · ownership.xml · derivative · entry 2 Yoskowitz Marc J · CIK 0001617306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,719 Underlying: American Depository Shares · 13,719 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Yoskowitz Marc JDirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015426 · ownership.xml · derivative · entry 1 Yoskowitz Marc J · CIK 0001617306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Jenkins AnnalisaDirector
|
GrantDeferred Restricted Stock Units · Derivative | 15,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015417 · ownership.xml · derivative · entry 2 Jenkins Annalisa · CIK 0001639481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,243 Underlying: American Depository Shares · 15,243 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Jenkins AnnalisaDirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015417 · ownership.xml · derivative · entry 1 Jenkins Annalisa · CIK 0001639481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Jacquet PierreDirector
|
GrantDeferred Restricted Stock Units · Derivative | 15,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015427 · ownership.xml · derivative · entry 2 Jacquet Pierre · CIK 0001783451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,243 Underlying: American Depository Shares · 15,243 shares Expires not disclosed F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:30 UTC |
Jacquet PierreDirector
|
GrantShare Options (Right to buy) · Derivative | 55,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0000950170-25-015427 · ownership.xml · derivative · entry 1 Jacquet Pierre · CIK 0001783451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: American Depositary Shares · 55,000 shares Expires 2035-02-05 F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer Read SEC document |
| January 25, 2025 Filed Jan 28, 2025 16:05 UTC |
Fox Christine AnnChief Financial Officer
|
GrantShare Options (Right to buy) · Derivative | 262,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0000950170-25-009793 · ownership.xml · derivative · entry 1 Fox Christine Ann · CIK 0002005755 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,000 Underlying: American Depository Shares · 262,000 shares Expires 2035-01-25 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| January 25, 2025 Filed Jan 28, 2025 16:05 UTC |
Hughes-Wilson AlexandraSee Remarks
|
GrantShare Options (Right to buy) · Derivative | 154,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0000950170-25-009789 · ownership.xml · derivative · entry 1 Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,000 Underlying: American Depository Shares · 154,000 shares Expires 2035-01-25 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| January 25, 2025 Filed Jan 28, 2025 16:05 UTC |
Sermon CharlesGeneral Counsel
|
GrantShare Options (Right to buy) · Derivative | 262,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0000950170-25-009791 · ownership.xml · derivative · entry 1 Sermon Charles · CIK 0001687318 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,000 Underlying: American Depository Shares · 262,000 shares Expires 2035-01-25 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| January 25, 2025 Filed Jan 28, 2025 21:05 UTC |
Scots-Knight DeniseChief Executive Officer
|
GrantShare Options (Right to buy) · Derivative | 825,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0000950170-25-009787 · ownership.xml · derivative · entry 1 Scots-Knight Denise · CIK 0001297000 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 825,000 Underlying: American Depository Shares · 825,000 shares Expires 2035-01-25 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| January 25, 2025 Filed Jan 28, 2025 16:05 UTC |
Lewicki John A.Chief Scientific Officer
|
GrantShare Options (Right to buy) · Derivative | 116,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0000950170-25-009794 · ownership.xml · derivative · entry 1 Lewicki John A. · CIK 0001553352 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,000 Underlying: American Depository Shares · 116,000 shares Expires 2035-01-25 F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter. F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC |
Fox Christine AnnChief Financial Officer
|
SaleAmerican Depositary Shares representing Ordinary Shares | 19,158 | $4.22 | $80,865.92 |
DisclosureSEC source: 0000950170-24-106970 · ownership.xml · nonDerivative · entry 2 Fox Christine Ann · CIK 0002005755 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,285 F1 · security: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. F2 · shares: Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.01 to $4.43, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.